"TBSF" (20%) Human Albumin Solution

מדינה: אוסטרליה

שפה: אנגלית

מקור: Department of Health (Therapeutic Goods Administration)

מרכיב פעיל:

Albumin, Quantity: 200 g/L

זמין מ:

CSL Behring Australia Pty Ltd

INN (שם בינלאומי):

Albumin

טופס פרצבטיות:

Injection, solution

הרכב:

Excipient Ingredients: octanoate; sodium

מסלול נתינה (של תרופות):

Intravenous

יחידות באריזה:

50mL, 100mL

סיווג:

Medicine Listed (Export Only)

סוג מרשם:

(S1) This Schedule is intentionally blank

סממני תרפויטית:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

leaflet_short:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

מצב אישור:

Listed (Export Only)

תאריך אישור:

2006-03-01